LYMRIT 37-01: UPDATED RESULTS OF A PHASE I/II STUDY OF 177 LU-LILOTOMAB SATETRAXETAN, A NOVEL CD37-TARGETED ANTIBODY- RADIONUCLIDE-CONJUGATE IN RELAPSED NHL PATIENTS
Kolstad, A., Madsbu, U., Beasley, M., Bayne, M., Illidge, T., O'Rourke, N., Lagerlöf, I., Hájek, R., Jurczak, W., Willenbacher, E., Blakkisrud, J., Muftuler Løndalen, A., Rojkjaer, L., Baylor Curtis,Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_142
Date:
June, 2017
File:
PDF, 93 KB
english, 2017